| 前收市價 | 2.5500 |
| 開市 | 4.0000 |
| 買盤 | 2.0000 |
| 賣出價 | 5.3000 |
| 拍板 | 25.00 |
| 到期日 | 2024-11-15 |
| 今日波幅 | 4.0000 - 4.0000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 16 |
Insider MonkeyGenmab A/S (GMAB): One of the Best Affordable Stocks Under $40 According to Short Sellers
We recently compiled a list of the 10 Best Affordable Stocks Under $40 According to Short Sellers. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other affordable stocks under $40. Several traders tend to profit from stocks through appreciation. However, some do the opposite– their idea […]
ZacksAbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use
AbbVie's (ABBV) Tepkinly gets conditional approval in the EU to treat third-line patients with relapsed or refractory follicular lymphoma as a second indication.
ZacksWall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet
The consensus price target hints at a 45.1% upside potential for Genmab (GMAB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
